Concepedia

Cost-effectiveness analysis of first-line treatment for chronic hepatitis B in China

Zonglin Dai, Irene Ol Wong, Chan Xie, Wenxiong Xu, Yu Xiang, Liang Peng, Eric H. Y. Lau

Clinical Microbiology and Infection · 2021 · 16 citations · 22 references

DOIFull text

Open access

Concepts

References

22

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Norah A. Terrault, Anna S. Lok, Brian J. McMahon et al. · Hepatology · 2018 · 4.3K citations · Full text

, , +17

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

George Lau, Teerha Piratvisuth, Kang Luo et al. · New England Journal of Medicine · 2005 · 1.5K citations · Full text

, , +14

Thresholds for the cost–effectiveness of interventions: alternative approaches

Elliot Marseille, Bruce A. Larson, Dhruv S. Kazi et al. · Bulletin of the World Health Organization · 2014 · 873 citations · Full text

, , +15

HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability

Gi‐Ae Kim, Young‐Suk Lim, Jihyun An et al. · Gut · 2013 · 418 citations

, , +16

Hepatitis B virus DNA levels and outcomes in chronic hepatitis B # †

Chien‐Jen Chen, Hwai‐I Yang, Uchenna H. Iloeje · Hepatology · 2009 · 347 citations

, , +17